Hjem › Syndrom med oblitererende bronkiolitt › Georgia
Kliniske studier for Syndrom med oblitererende bronkiolitt i Georgia
11 studier for Syndrom med oblitererende bronkiolitt søker deltakere på steder i Georgia.
Byer i Georgia
Offisiell studietekst (engelsk)
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
- Children's Healthcare of Atlanta - Egleston Hospital- Site Number : 8400003, Atlanta
RekruttererFase 2
Alder 1 til 18 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07116031An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
- Clayton Eye Clinical Research, Morrow
RekruttererFase 3
Alder 10 til 65 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07395232A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
- Childrens Healthcare of Atlanta, Atlanta
RekruttererFase 2
Alder 2 til 17 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07124078A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Emory University-Winship Cancer Institute, Atlanta
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06585774Repetitive Transcranial Magnetic Stimulation, a Form of Non-invasive Brain Stimulation, as a Possible Treatment for Post-stroke Fatigue
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
RekruttererFase 2
Alder 34 til 80 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05584124Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- Emory University, Atlanta
- Georgia Cancer Center, Augusta
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 25. aug. 2026 · NCT05919511A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- Emory University, Atlanta
RekruttererFase 2
Alder 2 og eldre · Alle kjønn · Oppdatert 16. jun. 2026 · NCT04710576A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Blood and Marrow Transplant Group of Georgia, Atlanta
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 20. mai 2026 · NCT06615050Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease
- Northside Hospital, Atlanta
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 20. apr. 2026 · NCT06046248A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Emory University Winship Cancer Institute, Atlanta
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 15. des. 2025 · NCT06619561Freedom-1 Study for Chronic Knee Pain
- Southern Pain and research, Jasper
- Vista Clinical Research/Summit Spine & Joint Centers, Newnan
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 13. feb. 2025 · NCT03877653Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.